The life sciences technology company will be able to offer services to the pharmacies associated with Legacy.
PrimeRx announced that it has formed a partnership with Legacy Pharmacy Group, a group purchasing organization for independent pharmacies in the New York region.1 This will provide PrimeRx, a pharmacy management software provider, with access to the more than 550 pharmacies in Legacy’s network.
In a press release, PrimeRx’s CEO Ketan Mehta said, “We are pleased to partner with the highly respected Legacy Pharmacy Group, which has a well-earned reputation for helping independent pharmacies operate at the highest levels of efficiency. Legacy pharmacies are committed to managing costs and protecting their bottom lines. PrimeRx is a natural fit for efficiency-focused pharmacies, and we look forward to introducing the system to network members.”
Legacy’s CEO Ritesh Shah also said, “This brings tremendous value to our GPO, our members will benefit from PrimeRx partnership.”
In July, PrimeRx launched PrimeRX MARKET, an online marketplace for pharmacies designed to provide competitive inventory options.2
In a press release, Mehta said, “We are thrilled to introduce PrimeRx MARKET to our solutions portfolio. PrimeRx has a strong track record of simplifying complex challenges. The drug procurement process for pharmacies, a major expense, requires precise contract compliance and inventory management to maintain cash flow and profitability. PrimeRx MARKET empowers pharmacies to source drugs intelligently and conveniently by integrating purchase and dispensing data, ensuring compliance and market agility. Our goal is to use data intelligence to streamline purchasing decisions, enabling pharmacies to remain profitable and dedicated to serving their patients."
Earlier, in June, PrimeRx announced the launch its PrimeRx Cloud technology solution, a digital platform designed specifically for independent pharmacies.3
At the time, Mehta said, “PrimeRx Cloud is the next step in pharmacy technology. We are proud to offer this addition to the PrimeRx product portfolio, which addresses the need for users to have flexibility in where, when, and how they manage their pharmacies."
In the same press release, PrimeRx’s chief technology officer Darrell Hyde said, “PrimeRx Cloud solves a number of serious problems facing today's busy pharmacies, including the need for increased flexibility and reduced IT overhead and risk. Pharmacy management no longer takes place just behind the pharmacy counter. Today's pharmacy owners are checking in from home, often long after the pharmacy has closed for the day. PrimeRx Cloud enables the modern owner to operate from anywhere while also removing the need to operate complex IT infrastructure in the pharmacy."
The company’s chief sales and marketing officer Tillmann Schwabe also said, “PrimeRx Cloud supports our goal of helping pharmacists build healthier communities. Our browser-based solution makes it easier for pharmacists to serve their patients, namely by reducing the administrative workload, which allows more time for in-person interactions."
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
FDA Grants Priority Review to GSK’s Gepotidacin for Uncomplicated Urinary Tract Infections
October 18th 2024Priority Review status for GSK’s New Drug Application for gepotidacin was based on promising results from the Phase III EAGLE-2 and EAGLE-3 trials, which demonstrated non-inferiority to nitrofurantoin in uncomplicated urinary tract infections.